Südzucker Valuation
Is SZU undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SZU when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SZU (€11.08) is trading below our estimate of fair value (€23.96)
Significantly Below Fair Value: SZU is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SZU?
Key metric: As SZU is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SZU's PE Ratio? | |
|---|---|
| PE Ratio | 6.7x |
| Earnings | €336.00m |
| Market Cap | €2.27b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 5.2x |
| PEG Ratio | -0.7x |
Price to Earnings Ratio vs Peers
How does SZU's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 20.1x | ||
AGR AGRANA Beteiligungs-Aktiengesellschaft | 26x | n/a | €678.0m |
MAN Josef Manner & Comp | 29.6x | n/a | €204.1m |
LOUP L.D.C | 7.5x | 1.1% | €2.3b |
300761 Jiangsu Lihua Animal Husbandry | 17.3x | 3.6% | CN¥17.1b |
SZU Südzucker | 6.7x | -10.2% | €2.3b |
Price-To-Earnings vs Peers: SZU is good value based on its Price-To-Earnings Ratio (6.7x) compared to the peer average (20x).
Price to Earnings Ratio vs Industry
How does SZU's PE Ratio compare vs other companies in the European Food Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: SZU is good value based on its Price-To-Earnings Ratio (6.7x) compared to the European Food industry average (13.4x).
Price to Earnings Ratio vs Fair Ratio
What is SZU's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 6.7x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SZU's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €11.08 | €10.98 -0.9% | 18.6% | €14.50 | €9.00 | n/a | 5 |
| Nov ’25 | €11.00 | €10.10 -8.2% | 11.4% | €12.00 | €9.00 | n/a | 4 |
| Oct ’25 | €11.34 | €11.10 -2.1% | 17.2% | €13.00 | €9.00 | n/a | 4 |
| Sep ’25 | €12.17 | €12.88 +5.8% | 1.7% | €13.00 | €12.50 | n/a | 4 |
| Aug ’25 | €11.95 | €12.88 +7.7% | 1.7% | €13.00 | €12.50 | n/a | 4 |
| Jul ’25 | €13.77 | €13.08 -5.0% | 4.6% | €14.00 | €12.30 | n/a | 4 |
| Jun ’25 | €14.08 | €12.80 -9.1% | 7.9% | €14.00 | €11.20 | n/a | 4 |
| May ’25 | €13.38 | €12.30 -8.1% | 10.2% | €14.00 | €11.00 | n/a | 4 |
| Apr ’25 | €13.28 | €13.05 -1.7% | 18.5% | €17.00 | €11.00 | n/a | 4 |
| Mar ’25 | €13.00 | €13.73 +5.6% | 17.7% | €17.00 | €11.20 | n/a | 3 |
| Feb ’25 | €12.99 | €13.73 +5.7% | 17.7% | €17.00 | €11.20 | n/a | 3 |
| Jan ’25 | €14.18 | €15.43 +8.8% | 15.8% | €17.30 | €12.00 | n/a | 3 |
| Dec ’24 | €14.15 | €15.86 +12.1% | 12.5% | €17.30 | €12.00 | n/a | 5 |
| Nov ’24 | €14.45 | €15.86 +9.8% | 12.5% | €17.30 | €12.00 | €11.00 | 5 |
| Oct ’24 | €14.12 | €16.44 +16.4% | 5.1% | €17.20 | €15.00 | €11.34 | 5 |
| Sep ’24 | €15.06 | €17.80 +18.2% | 13.9% | €22.00 | €15.00 | €12.17 | 5 |
| Aug ’24 | €15.84 | €17.80 +12.4% | 13.9% | €22.00 | €15.00 | €11.95 | 5 |
| Jul ’24 | €16.35 | €17.50 +7.0% | 12.8% | €21.50 | €15.00 | €13.77 | 5 |
| Jun ’24 | €15.95 | €17.50 +9.7% | 12.8% | €21.50 | €15.00 | €14.08 | 5 |
| May ’24 | €18.31 | €17.98 -1.8% | 14.0% | €21.90 | €15.00 | €13.38 | 4 |
| Apr ’24 | €15.47 | €16.40 +6.0% | 9.2% | €18.60 | €15.00 | €13.28 | 4 |
| Mar ’24 | €16.10 | €16.22 +0.7% | 8.6% | €18.60 | €15.00 | €13.00 | 5 |
| Feb ’24 | €14.94 | €16.10 +7.8% | 7.5% | €18.00 | €15.00 | €12.99 | 5 |
| Jan ’24 | €16.34 | €14.93 -8.6% | 10.1% | €17.50 | €12.50 | €14.18 | 6 |
| Dec ’23 | €14.13 | €13.95 -1.3% | 6.5% | €15.50 | €12.50 | €14.15 | 6 |
| Nov ’23 | €12.87 | €13.35 +3.7% | 6.3% | €15.00 | €12.50 | €14.45 | 6 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Altria Group
US$94.8b
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
ALTR
US$53.22
7D
4.8%
1Y
42.7%
Keurig Dr Pepper
US$42.9b
Owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally.
KDP
US$29.67
7D
-4.5%
1Y
2.0%
Anheuser-Busch InBev
€105.3b
Produces, distributes, exports, markets, and sells beer and beverages.
ABIN
€53.32
7D
-0.4%
1Y
-5.3%